Recommandations for the registration of drugs used in the treatment of osteoarthritis : an update on biochemical markers; ; et al in Osteoarthritis and Cartilage (2001), 9 Detailed reference viewed: 7 (2 ULg) Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density; ; et al in Journal of Bone and Mineral Research (1999), 14(S1), 136 Detailed reference viewed: 5 (1 ULg) Risedronate is well-tolerated in women with osteoporosis; ; et al in Journal of Bone and Mineral Research (1999), 14(S1), 538 Detailed reference viewed: 3 (1 ULg) Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass; ; et al in Calcified Tissue International (1999), 64(S1), 69 Detailed reference viewed: 5 (2 ULg) |
||